JP5578880B2 - 抗マラセチア菌剤 - Google Patents

抗マラセチア菌剤 Download PDF

Info

Publication number
JP5578880B2
JP5578880B2 JP2010039855A JP2010039855A JP5578880B2 JP 5578880 B2 JP5578880 B2 JP 5578880B2 JP 2010039855 A JP2010039855 A JP 2010039855A JP 2010039855 A JP2010039855 A JP 2010039855A JP 5578880 B2 JP5578880 B2 JP 5578880B2
Authority
JP
Japan
Prior art keywords
mastic
extract
antifungal
squalane
squalene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2010039855A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011173837A5 (enExample
JP2011173837A (ja
Inventor
信彦 桑野
真弓 小野
智文 宮本
初美 谷口
秀雄 美濃部
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alliance Co Ltd
Original Assignee
Alliance Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alliance Co Ltd filed Critical Alliance Co Ltd
Priority to JP2010039855A priority Critical patent/JP5578880B2/ja
Priority to CN2010800632196A priority patent/CN102905699A/zh
Priority to US13/576,061 priority patent/US20120316144A1/en
Priority to PCT/JP2010/057658 priority patent/WO2011104900A1/ja
Priority to KR1020127020169A priority patent/KR101435163B1/ko
Publication of JP2011173837A publication Critical patent/JP2011173837A/ja
Publication of JP2011173837A5 publication Critical patent/JP2011173837A5/ja
Application granted granted Critical
Publication of JP5578880B2 publication Critical patent/JP5578880B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
JP2010039855A 2010-02-25 2010-02-25 抗マラセチア菌剤 Active JP5578880B2 (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2010039855A JP5578880B2 (ja) 2010-02-25 2010-02-25 抗マラセチア菌剤
CN2010800632196A CN102905699A (zh) 2010-02-25 2010-04-30 抗真菌剂
US13/576,061 US20120316144A1 (en) 2010-02-25 2010-04-30 Antifungal agent
PCT/JP2010/057658 WO2011104900A1 (ja) 2010-02-25 2010-04-30 抗真菌剤
KR1020127020169A KR101435163B1 (ko) 2010-02-25 2010-04-30 항말라세지아제

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010039855A JP5578880B2 (ja) 2010-02-25 2010-02-25 抗マラセチア菌剤

Publications (3)

Publication Number Publication Date
JP2011173837A JP2011173837A (ja) 2011-09-08
JP2011173837A5 JP2011173837A5 (enExample) 2013-03-14
JP5578880B2 true JP5578880B2 (ja) 2014-08-27

Family

ID=44506340

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010039855A Active JP5578880B2 (ja) 2010-02-25 2010-02-25 抗マラセチア菌剤

Country Status (5)

Country Link
US (1) US20120316144A1 (enExample)
JP (1) JP5578880B2 (enExample)
KR (1) KR101435163B1 (enExample)
CN (1) CN102905699A (enExample)
WO (1) WO2011104900A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5578880B2 (ja) * 2010-02-25 2014-08-27 株式会社アライアンス 抗マラセチア菌剤
CN103462993B (zh) * 2013-09-06 2015-07-22 嵊州市林美生物科技有限公司 Aphanamgrandiol A在制备抗人体真菌药物中的应用
DE112015004182T5 (de) * 2014-09-12 2018-01-11 Maruha Nichiro Corporation Antimykotische Zusammensetzung umfassend antimykotisches Peptid und Terpenalkohol
EP3468530A4 (en) 2016-06-10 2020-03-11 Clarity Cosmetics Inc. NON-COMEDOGEN FORMULA FOR HAIR AND SCALP CARE AND METHOD FOR USE
CN110269824A (zh) * 2019-07-19 2019-09-24 安徽宝利行香料有限公司 乳香提取物在日用品及洗涤用品中的应用
CN110754362B (zh) * 2019-11-28 2021-06-25 杭州创美生物科技有限公司 一种富硒金线莲的培养基及其培育方法
CN111000744B (zh) * 2020-01-07 2021-10-15 拉芳家化股份有限公司 一种含协同增效去屑组合的洗发香波

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002238496A (ja) * 2001-02-19 2002-08-27 Araiansu:Kk 医療保健食品
EP1501527B1 (en) * 2002-05-01 2009-09-02 Lavipharm S.A. Use of mastic and its essential oils for the control of microbial infections
JP2008292773A (ja) * 2007-05-24 2008-12-04 Casio Electronics Co Ltd 帯電ローラ
JP2010100596A (ja) * 2008-10-21 2010-05-06 Araiansu:Kk マスティックとスクワランを配合した薬剤耐性菌感染予防の組成物
JP5578880B2 (ja) * 2010-02-25 2014-08-27 株式会社アライアンス 抗マラセチア菌剤

Also Published As

Publication number Publication date
KR20120102801A (ko) 2012-09-18
JP2011173837A (ja) 2011-09-08
KR101435163B1 (ko) 2014-09-01
WO2011104900A1 (ja) 2011-09-01
CN102905699A (zh) 2013-01-30
US20120316144A1 (en) 2012-12-13

Similar Documents

Publication Publication Date Title
LS Propolis in dentistry and oral cancer management
de Carvalho et al. Evidence-based studies and perspectives of the use of Brazilian green and red propolis in dentistry
KR101841181B1 (ko) 생약 추출물을 함유하는 치약 조성물
EP2775838B1 (en) Aqueous antimicrobial composition containing coniferous resin acids
Soundarajan et al. Antibacterial and anti-inflammatory effects of a novel herb-mediated nanocomposite mouthwash in plaque-induced gingivitis: a randomized controlled trial
EP3212288B1 (en) Formulations containing pomegranate seed oil, rosa canina fruit oil and inula viscosa oleoresin or extract
JP2011173837A5 (enExample)
JP2011173837A (ja) マスティックを原料とする抗真菌剤
WO2019234743A1 (en) Anti-inflammatory synergistic compositions comprising cannabinoids and licorice
Koch et al. Plant phenolics in the prevention and therapy of acne: A comprehensive review
US20230270807A1 (en) Antimicrobial compositions
JPH1053532A (ja) 植物抽出物含有抗アレルギー剤
KR20110082292A (ko) 아토피 및 여드름 피부에 효능을 보이는 황칠나무 추출물
US20250302904A1 (en) Extracts in eutectic solvent of olive oil polyphenols, compositions, uses and methods of preparation thereof
US10588979B1 (en) Cannabinoid and terpene-infused topical cream
JP2010100596A (ja) マスティックとスクワランを配合した薬剤耐性菌感染予防の組成物
WO2023107448A1 (en) Compositions for diminishing the signs of aging
JP2011153093A (ja) 脂肪前駆細胞分化促進剤
RU2582290C2 (ru) Стоматологический гель с ниосомами для лечения воспалительных и дистрофических заболеваний пародонта
KR101623553B1 (ko) 여드름 치료, 예방 또는 개선에 유효한 클로린 e6
US20170152285A1 (en) Extracting method of kuguacin, pharmaceutical composition comprising the kuguacin and use thereof
KR20220014613A (ko) 균총 조절용 조성물
KR20170065187A (ko) 티트리 잎 복합 추출물을 함유하는 여드름 개선용 화장료 조성물
JP2002238496A (ja) 医療保健食品
Sanadi et al. Phytotherapeutic Agentsin Periodontal Therapy: A Review

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100329

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100329

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100602

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130104

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130104

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20130104

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20130104

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20130104

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140304

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140502

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140701

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140708

R150 Certificate of patent or registration of utility model

Ref document number: 5578880

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250